Correlation Between Check Point and Arrowhead Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Check Point and Arrowhead Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Check Point and Arrowhead Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Check Point Software and Arrowhead Pharmaceuticals Corp, you can compare the effects of market volatilities on Check Point and Arrowhead Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Check Point with a short position of Arrowhead Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Check Point and Arrowhead Pharmaceuticals.

Diversification Opportunities for Check Point and Arrowhead Pharmaceuticals

-0.17
  Correlation Coefficient

Good diversification

The 3 months correlation between Check and Arrowhead is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Check Point Software and Arrowhead Pharmaceuticals Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrowhead Pharmaceuticals and Check Point is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Check Point Software are associated (or correlated) with Arrowhead Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrowhead Pharmaceuticals has no effect on the direction of Check Point i.e., Check Point and Arrowhead Pharmaceuticals go up and down completely randomly.

Pair Corralation between Check Point and Arrowhead Pharmaceuticals

Assuming the 90 days trading horizon Check Point Software is expected to generate 0.48 times more return on investment than Arrowhead Pharmaceuticals. However, Check Point Software is 2.09 times less risky than Arrowhead Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Arrowhead Pharmaceuticals Corp is currently generating about 0.04 per unit of risk. If you would invest  15,331  in Check Point Software on September 3, 2024 and sell it today you would earn a total of  2,871  from holding Check Point Software or generate 18.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy96.9%
ValuesDaily Returns

Check Point Software  vs.  Arrowhead Pharmaceuticals Corp

 Performance 
       Timeline  
Check Point Software 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Check Point Software has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Check Point is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Arrowhead Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Arrowhead Pharmaceuticals Corp are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Arrowhead Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Check Point and Arrowhead Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Check Point and Arrowhead Pharmaceuticals

The main advantage of trading using opposite Check Point and Arrowhead Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Check Point position performs unexpectedly, Arrowhead Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will offset losses from the drop in Arrowhead Pharmaceuticals' long position.
The idea behind Check Point Software and Arrowhead Pharmaceuticals Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Transaction History
View history of all your transactions and understand their impact on performance
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Valuation
Check real value of public entities based on technical and fundamental data